Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Gold/silver aren't the only precious metals making a killing

Even while gold, silver, and platinum steal most of the headlines , there are stealth bull markets advancing in other precious metals. Take palladium for instance. Indeed, while platinum may have the prestige, palladium has the profits. Pall...
Peter Krauth | October 28, 2012 |

Coronavirus Strikes Back. But Force Is Strong With Gold

We all fear the second wave of infections. But the U.S. hasn’t even controlled the first one! Bad news for Americans, but good news for gold. Please take a look at the chart below. As you can see, the epidemiological situation in the United States d...
Arkadiusz Sieron | June 30, 2020 |

The Duel Between Johnson and Parliament. Will Gold Win?

Boris Johnson struggles to push the Brexit agreement through the British Parliament. For it can bite back! Who wins this battle? One could hope that gold, but this is not so certain… Johnson’s Struggle, Explained On Thursday, the breaking news came ...
Arkadiusz Sieron | October 23, 2019 |

US Stock Market Enters Parabolic Price Move – Be Prepared, Part I

After the recent COVID-19 virus event and the global market concerns that will warrant caution for skilled traders and investors, the US stock markets have entered an upside parabolic trend that will likely end with a massive price collapse – extremely volatile and aggressiv...
Chris Vermeulen | June 23, 2020 |

Gold has immunity, silver has ratio

On Monday Wall Street pared back losses from last week’s sell-off, the worst since 2008, but it was only the promise of lowering interest rates, the return of the “punch bowl” hearkening back to recession-era stimulus, that has tempora...
Richard (Rick) Mills | March 3, 2020 |

What re-opening success or failure means for metals

“There is a Chinese curse which says ‘May he live in interesting times.’ Like it or not we live in interesting times. They are times of danger and uncertainty; but they are also more open to the creative energy of men than any other time in history.&CloseCurl...
Richard (Rick) Mills | May 22, 2020 |

Graphite: Why now is the time to invest

Remember when you used to take standardized tests in school with a yellow No. 2 graphite pencil? I can still remember myself in fourth grade filling in answer bubbles as my teacher scanned the room trying to catch anyone cheating. Back then, pencils were probably the onl...
Mike Kapsch | December 14, 2012 |

NGM Biopharma Shares Rise on Positive Topline Data from Phase 2 NASH Trial

Shares of NGM Biopharmaceuticals reached a new 52-week intraday high price after the company posted positive topline data from Cohort 4 of its Phase 2 study of aldafermin in NASH Patients. On a day when world financial markets traded lower across the board, ...
Streetwise Reports | February 25, 2020 |

Reata Pharma Shares Trading Higher After Reacquiring U.S. and Worldwide Licensing Rights

Shares of Reata Pharmaceuticals are trading 12% higher today after the firm announced it had reacquired all licensing rights in the U.S. for bardoxolone methyl and worldwide rights for omaveloxolone and other next-generation Nrf2 activators from AbbVie. Clinical-stage...
Streetwise Reports | October 15, 2019 |

Cypress Development Corp. (TSX.V:CYP) Clayton Valley Lithium Project versus Chinese LCE/ EV ...

Cypress Development Corp. (TSX.V:CYP) Clayton Valley Lithium Project versus Chinese LCE/ EV battery supply The pause in industrial activity brought about by the covid-19 crisis has led us to a fork in the road with respect to the direction we as a society take in ...
Richard (Rick) Mills | May 19, 2020 |
1 2 3 4 5 6 7 8 9 10 ...